The present invention relates generally to endoluminal devices, and more particularly to stents.
Stents and similar endoluminal devices have been used to expand a constricted vessel to maintain an open passageway through the vessel in many medical situations, for example, following angioplasty of a coronary artery. In these situations, stents are useful to prevent restenosis of the dilated vessel through proliferation of vascular tissues. Stents can also be used to reinforce collapsing structures in the respiratory system, the reproductive system, biliary ducts or any tubular body lumens. Whereas in vascular applications fatty deposits or “plaque” frequently cause the stenosis, in many other body lumens the narrowing or closing may be caused by malignant tissue.
Fluids have traditionally been used to pressurize the angioplasty balloons used to open restricted vessels. The balloons may have a variety of shapes including a coiled form. In such a device fluid is injected into the balloon to inflate the device and maintain turgidity. Shturman (U.S. Pat. No. 5,181,911) discloses a perfusion balloon catheter wound into a helically coiled shape with one end attached to a fitting and the other to a syringe for inflating the balloon with fluid. When the balloon is inflated, its coiled form allows blood flow thorough the open center of the structure. At the same time it is possible to actually have fluid flow within the balloon structure so that the syringe can deliver fluid into the balloon, fluid can flow through the balloon, and fluid can then exit through a second lumen in a catheter attached to the syringe.
Coiled stents that are connected to a catheter apparatus, as in Wang et al. (U.S. Pat. No. 5,795,318), are used for temporary insertion into a patient. Wang et al. discloses a coiled stent of shape-memory thermoplastic tube that can be converted from a relatively narrow diameter to a larger coiled form by heating. The narrow diameter coil is mounted at the end of a catheter over a balloon and in a preferred embodiment a resistive heating element runs down the length of the thermoplastic element. An electric current is applied to heat the element thereby softening it while the balloon is expanded to enlarge the diameter of the coil. Upon cooling the enlarged coil hardens and the balloon is withdrawn. After the temporary stent has performed its duty, it is again heated and removed while in the softened state. In one embodiment the thermoplastic tube is supplied with an additional lumen so that liquid drugs can flow into the stent and delivered through apertures or semi-permeable regions.
The attempt to kill or prevent proliferation cells is a common theme in clinical practice. This is generally true in vascular and non-vascular lumens. It is known that ionizing radiation can prevent restenosis and malignant growth. Although the effect of temperature extremes, e.g., cryogenic (cold) or hot temperatures, on cellular activity is not as well researched, it may provide a safer approach to control of tissue proliferation. Among the drawbacks of the prior art coiled balloons is that the balloon material is relatively weak so that expansion and contraction cause the balloon to fail. Failure of a balloon containing radioactive or cryogenic fluids could be catastrophic. It would be desirable to provide a catheter based, minimally invasive device for stenting support that could deliver hot or cryogenic or radioactive fluids or drugs and that would be sturdy and could remain in the body for extended periods of time, detached from the insertion device.
In its simplest embodiment the present invention is an endoluminal coil stent comprising a hollow tube formed into a series of loops or other known stent shapes which initially has a low profile and diameter. This structure can be delivered into a patient's vascular system and expanded to full size. The present invention to provides a stent that is hollow allowing the passage of fluid. The stent has either one or a plurality of passageways for fluid flow. The stent is attached to a catheter via a special fitting so that when engaged with the catheter, fluid flows freely from the catheter to the stent with a possible return circuit through the catheter. When disengaged, the fitting prevents leakage from the stent permitting the stent to remain in place in a patient's vasculature.
This invention provides a way of treating vascular areas affected with malignant growths or experiencing restenosis from smooth muscle cell proliferation, etc. The stent is inserted in a small diameter configuration and after being enlarged to a larger diameter, acts as a support device for the areas of restenosis or malignant growth. In addition, the stent can treat these affected areas in a unique way by flowing radioactive, heated or cryogenic fluids through the stent.
The present invention also provides a way of delivering drugs to an affected site. A stent to accomplish this purpose can be composed of several different materials. For example, the stent can formed from a metal or other material with small pores machined or otherwise formed (e.g., with a laser). When such a stent is filed with a drug, that drug slowly disperses through the pores. Alternatively, an entire metal tube or portions of the tube could be formed e.g., from sintered metal powder thereby forming a porous structure for drug delivery. Another embodiment would alternate a metal tube (for structural stability) with dispensing segments inserted at various intervals. The segments would be perforated to allow seepage of the drug or would be otherwise formed from a porous material. Another embodiment employs an expanded polytetrafluoroethylene (PTFE) tube around a support wire or metal tube in the form of a coiled stent so that a hollow passageway is created between the metal and the PTFE. A drug is flowed into this space and slowly dispensed through the porous PTFE.
One embodiment of the hollow stent of the present invention comprises a shape memory metal such as nitinol. Shape memory metals are a group of metallic compositions that that have the ability to return to a defined shape or size when subjected to certain thermal or stress conditions. Shape memory metals are generally capable of being deformed at a relatively low temperature and, upon exposure to a relatively higher temperature, return to the defined shape or size they held prior to the deformation. This enables the stent to be inserted into the body in a deformed, smaller state so that it assumes its “remembered” larger shape once it is exposed to a higher temperature (i.e. body temperature or heated fluid) in vivo.
Special fittings are incorporated at the ends of the hollow stent. These fittings facilitate the injection and removal of fluid and also allow the stent to be detached from the insertion device to be left in place in a patient. The hollow stent has an inlet and an outlet so that a complete fluid path can be created, and fluid can be continually circulated through the stent. In the simplest configuration the inlet and outlet are at opposite ends of the stent. However, if the stent is equipped with a plurality of lumens, two lumens can be connected at a distal end of the structure so that the outlet and inlet are both together at one end. Other arrangements can be readily envisioned by one of ordinary skill in the art.
The stent is inserted into the body while connected to a catheter in a small, deformed state. Once inside the patient's body the stent is advanced to a desired position and expanded to its larger full size. If the stent is composed of shape memory metal, for example, the stent expands from its small-deformed state to its remembered larger state due to the higher body temperature or due to the passage of “hot” fluid through the stent. Subsequently “treatment” fluid (e.g., heated, cryogenic or radioactive) is pumped through the catheter to the stent where it is circulated throughout the stent, treating the adjacent vascular walls. The catheter can either be left in place for a certain period of time or removed, leaving the fluid inside the stent. This would particularly be the case with radioactive fluid or with a porous drug delivery stent.
The stent can be removed by reattaching the catheter allowing one to chill and shrink the stent (in the case of a memory alloy). Alternatively, the device can readily be used in its tethered form to remove memory alloy stents of the present invention or of prior art design. For this purpose a device of the present invention is inserted into the vasculature to rest within the stent to be removed. Warm fluid is then circulated causing the stent to expand into contact with the memory alloy stent that is already in position. At this point cryogenic (e.g., low temperature) fluid is circulated causing the attached stent and the contacted stent to shrink so that the combination can be readily withdrawn.
These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
Referring now to the drawings, in which like reference numbers represent similar or identical structures throughout the drawings,
Inside the tubing 22 of stent 20, two fluid pathways exist. These pathways can be seen in the cross sectional view of FIG. 3. Pathways 26 and 28 have opposite flowing fluid streams and connect at the distal end 24 of stent 20. By allowing for opposite streams, radioactive, heated or cryogenic liquids can continuously flow through stent 20 for the purpose of killing or preventing proliferation of cells. By “heated” or “hot” is meant temperatures above body temperature. By “cryogenic” or “cold” is meant temperatures below body temperature. The stent 20 can either remain connected to a delivery catheter 30 for temporary insertion, or be detached for a more permanent insertion. In either case, fluid flow can be circulated throughout stent 20 prior to disconnection. In the simplest design, fluid passageways connected to the stent 20 are lumens of the delivery catheter so that when the catheter is withdrawn, fluid flow must cease.
It is also possible to provide separate flexible tubes that are threaded through the catheter so that the delivery catheter can be withdrawn leaving the relatively smaller fluid delivery tubes (not shown) behind. Preventing leakage of the fluid from the stent 20 after the catheter 30 is disconnected is accomplished through a valve mechanism contained in the catheter 30, or the stent 20 and/or both. In the example illustrated in
The catheter 30 comprises a catheter shaft 32, which further contains two fluid pathways 34 and 36 as seen in FIG. 2. At the distal end of catheter 30, the valve assembly 40 has small hollow needles 48 that are designed to puncture elastomer diaphragms 25. The catheter 30 is slightly larger in diameter than the stent member 20 so that the catheter tubing wall 32 forms a friction fit over the stent wall 22. This creates a seal between the catheter 30, and the stent 20 for fluid delivery and removal. Upon detaching the catheter 30 leakage from the stent 20 is prevented due to the self-healing properties of the diaphragms 25. Obviously, the back flow preventer 40 could be on the stent 20 and the diaphragms could be on the catheter 30.
As discussed above, stent 20 is inserted into the body to the desired site through the use of a catheter insertion device well known in the art.
By increasing the diameter of stent 20 at an affected location, the passageway is enlarged to permit increased blood flow. At the same time, fluids can pass through the interior of tubes 22 of the hollow stent 20 to treat the vascular wall. The walls of the vasculature can be treated by running either a radioactive, cryogenic or heated fluid through the stent 20 or by delivering a drug through a stent equipped for drug diffusion (e.g., through holes or a porous region).
A third embodiment of the invention,
In a fourth embodiment, a hollow coiled stent 90 is formed from polytetrafluoroethylene (PTFE) 92. In
A fifth embodiment of the invention is illustrated in FIG. 11 and described in a flow diagram shown in FIG. 12. This embodiment is a method for recapturing an existing shape memory metal stent already in the body. With reference to both
Having thus described a preferred embodiment of a hollow endoluminal stent, it should be apparent to those skilled in the art that certain advantages of the within system have been achieved. It should also be appreciated that various modifications, adaptations, and alternative embodiments thereof may be made within the scope and spirit of the present invention. For example, a hollow stent with a coiled, tubular shape has been illustrated, however, many other possibilities exist for the shape and size of the hollow stent. In addition, the passageways are illustrated as round but could take on a variety of other shapes. The described embodiments are to be considered illustrative rather than restrictive. The invention is further defined by the following claims.
This application is a division of application Ser. No. 09/975,743, filed Oct. 11, 2001, now U.S. Pat. No. 6,623,519, which is a division of application Ser. No. 09/321,496, filed May 27, 1999, now U.S. Pat. No. 6,358,276, which claims the benefit of U.S. Provisional Application No. 60/105,768, filed Sep. 30, 1998. This application expressly incorporates by reference the entirety of each of the above-mentioned applications as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
3868956 | Alfidi et al. | Mar 1975 | A |
4307723 | Finney | Dec 1981 | A |
4503569 | Dotter | Mar 1985 | A |
4531933 | Norton et al. | Jul 1985 | A |
4694838 | Wijayarthna et al. | Sep 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4762130 | Fogarty et al. | Aug 1988 | A |
4795458 | Regan | Jan 1989 | A |
4813925 | Anderson, Jr. et al. | Mar 1989 | A |
4820298 | Leveen et al. | Apr 1989 | A |
4881939 | Newman | Nov 1989 | A |
4887996 | Bengmark | Dec 1989 | A |
4917666 | Solar et al. | Apr 1990 | A |
5147370 | McNamara et al. | Sep 1992 | A |
5156620 | Pigott | Oct 1992 | A |
5163928 | Hobbs et al. | Nov 1992 | A |
5181911 | Shturman | Jan 1993 | A |
5201901 | Harada et al. | Apr 1993 | A |
5226888 | Arney | Jul 1993 | A |
5370691 | Samson | Dec 1994 | A |
5380307 | Chee et al. | Jan 1995 | A |
5441516 | Wang et al. | Aug 1995 | A |
5445594 | Elist | Aug 1995 | A |
5536274 | Neuss | Jul 1996 | A |
5545135 | Iacob et al. | Aug 1996 | A |
5562641 | Flomenblit et al. | Oct 1996 | A |
5649978 | Samson | Jul 1997 | A |
5669931 | Kupiecki et al. | Sep 1997 | A |
5676685 | Razavi | Oct 1997 | A |
5697968 | Rogers et al. | Dec 1997 | A |
5795318 | Wang et al. | Aug 1998 | A |
5882335 | Leone et al. | Mar 1999 | A |
5902266 | Leone et al. | May 1999 | A |
6050986 | Hektner | Apr 2000 | A |
6053900 | Brown et al. | Apr 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6149677 | Dobak, III | Nov 2000 | A |
6258118 | Baum et al. | Jul 2001 | B1 |
6348067 | Baum et al. | Feb 2002 | B1 |
6413273 | Baum et al. | Jul 2002 | B1 |
6579305 | Lashinski | Jun 2003 | B1 |
20020161427 | Rabkin et al. | Oct 2002 | A1 |
Number | Date | Country | |
---|---|---|---|
20040044394 A1 | Mar 2004 | US |
Number | Date | Country | |
---|---|---|---|
60105769 | Sep 1998 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09975743 | Oct 2001 | US |
Child | 10638182 | US | |
Parent | 09321496 | May 1999 | US |
Child | 09975743 | US |